Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence
Neuropsychopharmacology
.
2018 Mar;43(4):928.
doi: 10.1038/npp.2017.245.
Authors
Brian Reed
,
Eduardo R Butelman
,
Rebecca S Fry
,
Rachel Kimani
,
Mary Jeanne Kreek
PMID:
29422497
PMCID:
PMC5809793
DOI:
10.1038/npp.2017.245
Abstract
This corrects the article DOI: 10.1038/npp.2017.205.
Publication types
Published Erratum